Mind Medicine Stock Analysis

MNMD Stock  USD 7.74  0.27  3.37%   
Mind Medicine is fairly valued with Real Value of 7.56 and Target Price of 8.0. The main objective of Mind Medicine stock analysis is to determine its intrinsic value, which is an estimate of what Mind Medicine is worth, separate from its market price. There are two main types of Mind Medicine's stock analysis: fundamental analysis and technical analysis.
The Mind Medicine stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Mind Medicine's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mind Medicine. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For information on how to trade Mind Stock refer to our How to Trade Mind Stock guide.

Mind Stock Analysis Notes

About 49.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 2.93. Mind Medicine last dividend was issued on the 27th of February 2020. The entity had 1:15 split on the 29th of August 2022. Mind Medicine Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology. It also develops MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. Mind Medicine operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 41 people. To find out more about Mind Medicine contact Robert Barrow at 212-220-6633 or learn more at https://www.mindmed.co.

Mind Medicine Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Mind Medicine's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Mind Medicine or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Mind Medicine generated a negative expected return over the last 90 days
Mind Medicine has high historical volatility and very poor performance
Net Loss for the year was (95.73 M) with profit before overhead, payroll, taxes, and interest of 0.
Mind Medicine currently holds about 105.74 M in cash with (64.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.71.
Mind Medicine has a frail financial position based on the latest SEC disclosures
Latest headline from zacks.com: Is Mind Medicine MindMed Outperforming Other Medical Stocks This Year

Mind Medicine Upcoming and Recent Events

14th of March 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
14th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Mind Largest EPS Surprises

Earnings surprises can significantly impact Mind Medicine's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-05-04
2023-03-31-0.42-0.52-0.123 
2024-03-07
2023-12-31-0.46-0.59-0.1328 
2022-08-11
2022-06-30-0.75-0.60.1520 
View All Earnings Estimates

Mind Medicine Environmental, Social, and Governance (ESG) Scores

Mind Medicine's ESG score is a quantitative measure that evaluates Mind Medicine's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Mind Medicine's operations that may have significant financial implications and affect Mind Medicine's stock price as well as guide investors towards more socially responsible investments.

Mind Medicine Thematic Classifications

In addition to having Mind Medicine stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Biotech Idea
Biotech
Biotechnology and pharmaceuticals production and services

Mind Stock Institutional Investors

Shares
Two Sigma Investments Llc2024-03-31
712.2 K
Vanguard Group Inc2024-03-31
562.9 K
Geode Capital Management, Llc2024-03-31
389.4 K
Millennium Management Llc2024-03-31
388.2 K
Tang Capital Management Llc2024-03-31
300 K
Ikarian Capital, Llc2024-03-31
297.5 K
Susquehanna International Group, Llp2024-03-31
269.6 K
Hrt Financial Llc2024-03-31
207.3 K
Charles Schwab Investment Management Inc2024-03-31
197.2 K
Deep Track Capital, Lp2024-03-31
6.7 M
Driehaus Capital Management Llc2024-03-31
2.5 M
Note, although Mind Medicine's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Mind Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 556.29 M.

Mind Profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.92)(0.97)
Return On Capital Employed(1.02)(1.07)
Return On Assets(0.77)(0.81)
Return On Equity(1.23)(1.29)

Management Efficiency

Mind Medicine has return on total asset (ROA) of (0.2761) % which means that it has lost $0.2761 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7679) %, meaning that it created substantial loss on money invested by shareholders. Mind Medicine's management efficiency ratios could be used to measure how well Mind Medicine manages its routine affairs as well as how well it operates its assets and liabilities. As of June 18, 2024, Return On Tangible Assets is expected to decline to -0.97. In addition to that, Return On Capital Employed is expected to decline to -1.07. The current year's Debt To Assets is expected to grow to 0.12, whereas Total Assets are forecasted to decline to about 119.5 M.
Last ReportedProjected for Next Year
Book Value Per Share 2.00  1.90 
Tangible Book Value Per Share 1.47  1.40 
Enterprise Value Over EBITDA(0.64)(0.67)
Price Book Value Ratio 1.83  1.74 
Enterprise Value Multiple(0.64)(0.67)
Price Fair Value 1.83  1.74 
Enterprise Value57.7 M114.7 M
The analysis of Mind Medicine's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Mind Medicine's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Mind Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta
2.43
Return On Assets
(0.28)
Return On Equity
(0.77)

Technical Drivers

As of the 18th of June 2024, Mind Medicine secures the Downside Deviation of 6.33, risk adjusted performance of 0.0971, and Mean Deviation of 5.46. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mind Medicine, as well as the relationship between them. Please verify Mind Medicine treynor ratio, as well as the relationship between the downside variance and kurtosis to decide if Mind Medicine is priced some-what accurately, providing market reflects its recent price of 7.74 per share. Given that Mind Medicine has jensen alpha of 1.08, we recommend you to check Mind Medicine's last-minute market performance to make sure the company can sustain itself at a future point.

Mind Medicine Price Movement Analysis

Execute Study
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Mind Medicine middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Mind Medicine. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Mind Medicine Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Mind Medicine insiders, such as employees or executives, is commonly permitted as long as it does not rely on Mind Medicine's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Mind Medicine insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Mind Medicine Predictive Daily Indicators

Mind Medicine intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Mind Medicine stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Mind Medicine Corporate Filings

F4
12th of June 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
11th of June 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
8K
8th of May 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
30th of April 2024
Other Reports
ViewVerify
26th of April 2024
Other Reports
ViewVerify
2nd of April 2024
Other Reports
ViewVerify
8K
1st of April 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
26th of March 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify

Mind Medicine Forecast Models

Mind Medicine's time-series forecasting models are one of many Mind Medicine's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Mind Medicine's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Mind Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Mind Medicine prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Mind shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Mind Medicine. By using and applying Mind Stock analysis, traders can create a robust methodology for identifying Mind entry and exit points for their positions.
Last ReportedProjected for Next Year

Current Mind Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Mind analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Mind analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
8.0Strong Buy4Odds
Mind Medicine current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Mind analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Mind stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Mind Medicine, talking to its executives and customers, or listening to Mind conference calls.
Mind Analyst Advice Details

Mind Stock Analysis Indicators

Mind Medicine stock analysis indicators help investors evaluate how Mind Medicine stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Mind Medicine shares will generate the highest return on investment. By understating and applying Mind Medicine stock analysis, traders can identify Mind Medicine position entry and exit signals to maximize returns.
Begin Period Cash Flow142.1 M
Long Term Debt14.1 M
Common Stock Shares Outstanding39.2 M
Total Stockholder Equity78.1 M
Cash And Short Term Investments99.7 M
Cash99.7 M
Accounts Payable4.1 M
Net Debt-85.6 M
50 Day M A8.8689
Total Current Liabilities32.2 M
Other Operating Expenses93.9 M
Non Current Assets Total20.7 M
Non Currrent Assets Other224 K
Stock Based Compensation15.5 M

Complementary Tools for Mind Stock analysis

When running Mind Medicine's price analysis, check to measure Mind Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mind Medicine is operating at the current time. Most of Mind Medicine's value examination focuses on studying past and present price action to predict the probability of Mind Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mind Medicine's price. Additionally, you may evaluate how the addition of Mind Medicine to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Bonds Directory
Find actively traded corporate debentures issued by US companies